Gynäkologie


Anatomie und Physiologie der weiblichen Geschlechtsorgane
Fehlbildungen der weiblichen Geschlechtsorgane
Lage- und Haltungsveränderungen der Gebärmutter

Gynäkologische Untersuchungen
Gynäkologische Operationen und Eingriffe
Schwangerschaft, Geburt, Wochenbett
Endometriose
Entzündungen der weiblichen Geschlechtsorgane

Hormonsystem
Prämenstruelles Syndrom
Sexualstörungen der Frau
Tumore der weiblichen Geschlechtsorgane
Unfruchtbarkeit der Frau
Verhütung
Wechseljahre

Häufige Erkrankungen :
Gesund Abnehmen
Akne
Blasenentzündung
Bulimie
Cellulite-Tipps
Diabetes
Herzerkrankungen bei Frauen
Magersucht
Multiple Sklerose
Osteoporose

Erster Weltkongress zur seelischen Gesundheit der Frau

27. - 31. März 2001 in Berlin

Kongress zur psychischen Gesundheit der Frau

Prof. Dr. Uriel Halbreich:

Sex Hormones and Mood

 

Worldwide, the prevalence of depression in women is significantly greater than in men. Available data suggest that estrogen, or its absence, is strongly implicated in the regulation of mood and behavior, as well as in the pathobiology of mood disorders.

 

The multiple effects and complex interactions of estrogens have been well documented, although specific, multifaceted role of estrogen in each dysphoric state has yet to be distinguished. Several facts suggest that estrogen exerts a vital role in the precipitation and course of mood disorders in women. Gender differences in the prevalence of depression first appear after menarche, continue through reproductive age, and dissipate after perimenopause. Periods of hormonal fluctuations or estrogen instability (i.e., premenstruai, postpartum, perimenopause) have been associated with increased vulnerability to depression among susceptible women. lt is plausible that the phenotype of these depressions is distinguishable.

 

Based on current knowledge, estrogen treatment for affective disorders may be efficacious in two situations:

1 To stabilize and restore disrupted homeostasis as with premenstrual, postpartum, or perimenopausal conditions;

2. To act as a psychomodulator during periods of decreased estrogen levels and increased vulnerability to dysphoric mood, as with postmenopausal women. lt remains unclear whether estrogen may be efficacious as a sole antidepressant, but there is growin~ evidence suggesting that it may be an efficacious adjunct to SSRI's.

 

Top
Zur Übersicht:
Erster Weltkongress zur
seelischen Gesundheit der Frau

 

 


MedizInfo®Homepage
zur Startseite

zur Übersicht
des Unterthemas
zur Übersicht
des Oberthemas